-transparent.png){kind=logo}
In the course of screening for microbial products with antitumor activity, new antitumor agents, clecarmycins, were isolated from culture broth of Streptomyces sp. DO-114. The antibiotics were produced in a fermentation medium supplemented with a highly porous polymer resin which adsorbs antibiotics and results in a increase of titer. Active materials were separated from the polymer resin by solvent extraction procedure and two components named clecarmycin A1 and C were isolated by silica gel column chromatography. These were active against bacteria, and showed antiproliferative activities against human HeLa S3 cells. Clecarmycins exhibited antitumor activity against leukemia P388 and sarcoma 180 in mice.
N Fujii, and
T Katsuyama, and
E Kobayashi, and
M Hara, and
H Nakano
December 1990,
The Journal of antibiotics,
N Fujii, and
T Katsuyama, and
E Kobayashi, and
M Hara, and
H Nakano
January 1991,
The Journal of antibiotics,
N Fujii, and
T Katsuyama, and
E Kobayashi, and
M Hara, and
H Nakano
March 1998,
The Journal of antibiotics,
N Fujii, and
T Katsuyama, and
E Kobayashi, and
M Hara, and
H Nakano
May 2003,
The Journal of antibiotics,
N Fujii, and
T Katsuyama, and
E Kobayashi, and
M Hara, and
H Nakano
February 1992,
The Journal of antibiotics,
N Fujii, and
T Katsuyama, and
E Kobayashi, and
M Hara, and
H Nakano
November 1975,
The Journal of antibiotics,
N Fujii, and
T Katsuyama, and
E Kobayashi, and
M Hara, and
H Nakano
August 1996,
The Journal of antibiotics,
N Fujii, and
T Katsuyama, and
E Kobayashi, and
M Hara, and
H Nakano
October 1983,
The Journal of antibiotics,
N Fujii, and
T Katsuyama, and
E Kobayashi, and
M Hara, and
H Nakano
December 1990,
The Journal of antibiotics,
N Fujii, and
T Katsuyama, and
E Kobayashi, and
M Hara, and
H Nakano
March 1981,
The Journal of antibiotics,
